EKF — EKF Diagnostics Holdings Income Statement
0.000.00%
Last trade - 00:00
- £125.23m
- £122.70m
- £52.61m
- 85
- 27
- 93
- 80
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 44.9 | 65.3 | 81.8 | 66.6 | 52.6 |
Cost of Revenue | |||||
Gross Profit | 23.7 | 37.4 | 39.4 | 30.8 | 24.4 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 39.1 | 48.4 | 60.1 | 75.6 | 50.5 |
Operating Profit | 5.78 | 16.9 | 21.7 | -8.97 | 2.08 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 5.52 | 15.4 | 21.4 | -8.94 | 2.13 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3.93 | 11.4 | 16.2 | -9.58 | 2.73 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 3.68 | 11.1 | 15.9 | -10.1 | 2.35 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 3.68 | 11.1 | 15.9 | -10.1 | 2.35 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.007 | 0.022 | 0.035 | 0.003 | 0.009 |
Dividends per Share |